Fortis Healthcare Ltd (FORTIS) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Fortis Healthcare Ltd. recommended a dividend of INR 1 per share (10% of face value) for the third consecutive year, reflecting strong fundamentals and earnings growth.
- Consolidated revenues reached INR 7,783 crores in FY25, a 12.9% YoY growth, driven primarily by the hospital business.
- Consolidated operating EBITDA increased 25.3% YoY to INR 1,588 crores, with a margin of 20.4% compared to 18.4% in FY24.
- Hospital business EBITDA margins improved from 18.6% to 20.5% in FY25, contributing 84% to both consolidated revenue and EBITDA.
- Reported PAT before exceptional items increased 42.8% YoY to INR 899 crores.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.